Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin

被引：0
|
作者：
Arrigo, Richard
Samanta, Arun
Griffith, Shanthini
Parekh, Ravish M.
Korogodsky, Maria
Rao, Kiran V.
Fisher, Adrian
Wilson, Dorian
Klein, Kenneth M.
Koneru, Baburao
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [1] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [2] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 48 - 49
  • [3] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    LIVER TRANSPLANTATION, 2003, 9 (06) : C6 - C6
  • [4] Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C
    Durante-Mangoni, E.
    Ragone, E.
    Pinto, D.
    Iossa, D.
    Covino, F. E.
    Maiello, C.
    Utili, R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 299 - 303
  • [5] Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    Neff, GW
    Montalbano, M
    O'Brien, CB
    Nishida, S
    Safdar, K
    Bejarano, PA
    Khaled, AS
    Ruiz, P
    Slapak-Green, G
    Lee, M
    Nery, J
    De Medina, M
    Tzakis, A
    Schiff, ER
    TRANSPLANTATION, 2004, 78 (09) : 1303 - 1307
  • [6] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [7] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [8] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [9] Interferon alfa and ribavirin for orthotopic liver transplant recipients with recurrent hepatitis C.
    Firpi, RJ
    Abdelmalek, MF
    Lauwers, GY
    Nelson, DR
    GASTROENTEROLOGY, 2000, 118 (04) : A1018 - A1018
  • [10] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
12345